Filing Details

Accession Number:
0001209191-11-021924
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-04-06 08:49:07
Reporting Period:
2011-04-04
Filing Date:
2011-04-06
Accepted Time:
2011-04-06 08:49:07
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1145404 Cornerstone Therapeutics Inc CRTX Pharmaceutical Preparations (2834) 043523569
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1304113 William Kenneth Andrew Powell C/O Cornerstone Therapeutics
1255 Crescent Green Drive, Suite 250
Cary NC 27518
Evp, General Counsel No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2011-04-04 2,000 $6.53 100,100 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 19, 2010.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.51 to $6.54, inclusive. The reporting person undertakes to provide to Cornerstone Therapeutics Inc., any security holder of Cornerstone Therapeutics Inc., or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.